Package 50090-4049-0

{"route": ["ORAL"], "spl_id": "1b5f8619-c60e-4e63-857b-3cb582b64276", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993541"], "spl_set_id": ["9d08b4ae-077d-4cd8-9ca4-8d5cd63f400b"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-4049-0)", "package_ndc": "50090-4049-0", "marketing_start_date": "20190111"}, {"sample": false, "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-4049-1)", "package_ndc": "50090-4049-1", "marketing_start_date": "20190111"}, {"sample": false, "description": "60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-4049-2)", "package_ndc": "50090-4049-2", "marketing_start_date": "20190111"}], "brand_name": "Bupropion Hydrochloride XL", "product_id": "50090-4049_1b5f8619-c60e-4e63-857b-3cb582b64276", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "50090-4049", "generic_name": "Bupropion Hydrochloride", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "XL", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA077715", "marketing_category": "ANDA", "marketing_start_date": "20081126", "listing_expiration_date": "20261231"}